Navigation Links
New muscular dystrophy treatment shows promise in early study led by Children's National
Date:9/17/2013

WASHINGTON, DC A preclinical study led by researchers at Children's National Medical Center has found that a new oral drug shows early promise for the treatment of Duchenne muscular dystrophy (DMD). The results, published in EMBO Molecular Medicine, show that the drug, VBP15, decreases inflammation and protects and strengthens muscle without the harsh side effects linked to current treatments with glucocorticoids such as prednisone.

Duchenne muscular dystrophy results in severe muscle degeneration and affects approximately 180,000 patients worldwide, mostly children. The current standard treatment uses glucocorticoids, but is limited due to serious side effects leading to fragile bones and suppression of both the immune system and growth.

"These findings, while preliminary, are very promising for advancing the treatment of this disease, which causes disability in so many children worldwide," said Eric P. Hoffman, PhD, director of the Center for Genetic Medicine Research at Children's National. "The study also suggests the potential for new strategies in very early treatment, which could further benefit patients."

The Children's National research team also observed that VBP15 inhibits the transcription factor NF-κB, a key cell-signaling molecule found in most cell types that plays a role in inflammation and tissue damage. The team previously found that NF-κB is active in dystrophin-deficient muscle years before the onset of symptoms, suggesting that very early treatment of Duchenne muscular dystrophy patients with VBP15 may prevent or delay the onset of some clinical symptoms.

"VBP15 has an additional property of addressing membrane defects in dystrophic muscle cells," remarked

Contact: Emily Hartman
ehartman@childrensnational.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Combined therapy could repair and prevent damage in Duchenne muscular dystrophy
2. New drug improves walking performance for Duchenne muscular dystrophy patients
3. Experimental gene therapy treatment for Duchenne muscular dystrophy offers hope for youngster
4. Researchers generate a mutant mouse model useful in the treatment of neuromuscular diseases
5. Scientists discover needle in a haystack for muscular dystrophy patients
6. Tamoxifen ameliorates symptoms of Duchenne muscular dystrophy
7. Stem-cell approach shows promise for Duchenne muscular dystrophy
8. Fred Hutchinson Cancer Research Center partners with GlaxoSmithKline to develop muscular dystrophy therapeutics
9. Another muscular dystrophy mystery solved; MU scientists inch closer to a therapy for patients
10. Protein injection points to muscular dystrophy treatment
11. Researchers discover 2 genetic flaws behind common form of inherited muscular dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... 2009It has long been suggested that healthy folate (the ... goes hand in hand with healthy nervous system development ... issue of the Journal of Child Psychology and ... linked to the development of attention-deficit/hyperactivity problems in children ...
... Technologies, a start-up company established by University of Delaware ... commercialize a high-precision detector -- a planar array infrared ... in solids, liquids, and gases, in quantities as small ... The revolutionary technology holds promise in multiple applications, ...
... wheat and barley lines resistant to Crown Rot a ... in lost yield every year. Crown Rot, which is ... by the fungus Fusarium . Dr Chunji Liu ... sophisticated screening methods to scan over 2400 wheat lines and ...
Cached Biology News:UD start-up company prepares to commercialize novel detector for medical, military applications 2UD start-up company prepares to commercialize novel detector for medical, military applications 3UD start-up company prepares to commercialize novel detector for medical, military applications 4
(Date:5/27/2015)... Calif. , May 27, 2015  Two years ... biotech professionals, hackers and citizen scientists, Oakland ... $30,000 crowdfunding campaign promoting its mission to democratize science ... Temescal District. ... Based out of ...
(Date:5/27/2015)... May 27, 2015 ­ Caris Life Sciences®, ... of precision medicine, today announced it has appointed the ... center of excellence site in the Caris Centers of ... Levine Cancer Institute is one of the largest cancer ... 11,000 new cancer patients annually. Derek Raghavan , ...
(Date:5/26/2015)... CITY , Kalifornien und HILDEN, Deutschland, ... QIAGEN Clinical Insight ® ... von Genvarianten und die Erstellung dazugehöriger Berichte; ... ESHG     QIAGEN N.V. (NASDAQ: ... gab heute die Markteinführung von QIAGEN Clinical ...
(Date:5/26/2015)... May 26, 2015 Tianyin Pharmaceutical Inc. (NYSE ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... the Company,s Annual Meeting of Shareholders for fiscal year ... held at the Company,s office located in ... 9:00 AM (local time in Chengdu, China ...
Breaking Biology Technology:East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 2Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3
... June 19 /Xinhua-PRNewswire/ --,Shenzhen Beike Biotechnology Co., Ltd. ... providing safe and effective stem cell applications for,medical ... medical stem cell storage and processing facility in ... Storage Facility will be,one of the most highly ...
... Canopus,BioPharma, Inc. (OTC: CBIA), has confirmed the efficacy ... agent and has also demonstrated the,synergistic effect of ... (Erbitux) in two mice lung cancer models., ... "We at,Canopus are encouraged with the discovery of ...
... 19 Iomai,Corporation (Nasdaq: IOMI ) announced ... Alexander Von Gabain, Ph. D., the Chief Scientific,Officer ... at the Biotechnology,Industry Organization,s International Convention at a ... session will begin at 4 p.m. in room ...
Cached Biology Technology:Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 2Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 3Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 4CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux). 2Iomai, Intercell Chief Scientific Officers to Speak on Future of Vaccines at BIO International Convention Today 2
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
... Versatile state of the Art ... flask to dual 38,000 L fermentation. ... scale to production. Aseptic operation ... Batch, Fed-Batch, and Continuous Modes. ...
Request Info...
Immunogen: VDAC3 Protein Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: